These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1775934)

  • 1. Recent advances in the management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC
    Scand J Gastroenterol Suppl; 1991; 188():101-7. PubMed ID: 1775934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of gastro-oesophageal reflux disease with omeprazole.
    Lundell L
    Scand J Gastroenterol Suppl; 1994; 201():74-8. PubMed ID: 8047829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic strategy in the treatment of gastroesophageal reflux].
    Zeitoun P; Carteret E; Bouché O
    Acta Gastroenterol Belg; 1990; 53(5-6):568-72. PubMed ID: 1983374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role and limitations of H2-receptor antagonists in the treatment of gastro-oesophageal reflux disease.
    Colin-Jones DG
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():9-14. PubMed ID: 7495945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of gastroesophageal reflux disease.
    Kaplan B; Koppelo KL
    W V Med J; 1994 Dec; 90(12):510-7. PubMed ID: 7863640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic principles in gastroesophageal reflux].
    Chassany O; Elkharrat D; Bergmann JF; Segrestaa JM
    Rev Med Interne; 1995; 16(12):960-70. PubMed ID: 8570962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease.
    Havelund T; Aalykke C; Rasmussen L
    Eur J Gastroenterol Hepatol; 1997 May; 9(5):509-14. PubMed ID: 9187886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
    Galmiche JP
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S3-6. PubMed ID: 10929891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly.
    Gawrieh S; Shaker R
    Drugs Aging; 2003; 20(7):509-16. PubMed ID: 12749748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Numans ME; Bonis PA; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD002095. PubMed ID: 10796857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approaches in the medical treatment of oesophageal reflux.
    Richter JE; Castell DO
    Drugs; 1981 Apr; 21(4):283-91. PubMed ID: 7014172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
    Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: management of mild and severe gastro-oesophageal reflux disease.
    Tytgat GN
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():52-6. PubMed ID: 12786613
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.